1. Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments
   Wanli Sun et al, 2022, Frontiers in Cardiovascular Medicine CrossRef
2. Neurotoxicity of the antineoplastic drugs: “Doxorubicin” as an example
   Ghadha Ibrahim Fouad et al, 2024, Journal of Molecular Histology CrossRef
3. Non-coding RNAs: targets for Chinese herbal medicine in treating myocardial fibrosis
   Minghui Wang et al, 2024, Frontiers in Pharmacology CrossRef
4. LncRNA HOTAIR promotes myocardial fibrosis in atrial fibrillation through binding with PTBP1 to increase the stability of Wnt5a
   Wei Tan et al, 2022, International Journal of Cardiology CrossRef
5. Pirfenidone inhibits stromal collagen deposition and improves intra-tumoral delivery and antitumor efficacy of Pegylated liposomal doxorubicin
   Tiantian Cai et al, 2023, Biomedicine & Pharmacotherapy CrossRef
6. Biomarkers of heart failure: advances in omics studies
   Kuo Chi et al, 2024, Molecular Omics CrossRef
7. Identification of Hub Genes in the Remodeling of Non-Infarcted Myocardium Following Acute Myocardial Infarction
   Lingxiao Wang et al, 2022, Journal of Cardiovascular Development and Disease CrossRef
8. MiR-133b as a crucial regulator of TCS-induced cardiotoxicity via activating β-adrenergic receptor signaling pathway in zebrafish embryos
   Xiancheng Wan et al, 2023, Environmental Pollution CrossRef
9. LncRNA AC006064.4–201 serves as a novel molecular marker in alleviating cartilage senescence and protecting against osteoarthritis by destabilizing CDKN1B mRNA via interacting with PTBP1
   Panyang Shen et al, 2023, Biomarker Research CrossRef
10. Clinical Significance of Non-Coding RNA Regulation of Programmed Cell Death in Hepatocellular Carcinoma
    Wuyu Chen et al, 2023, Cancers CrossRef
11. Protective effect of limonin against doxorubicin-induced cardiotoxicity via activating nuclear factor - like 2 and Sirtuin 2 signaling pathways
    Jie Deng et al, 2021, Bioengineered CrossRef
12. MicroRNAs as Biomarkers and Therapeutic Targets in Doxorubicin-Induced Cardiomyopathy: A Review
    Liuying Chen et al, 2021, Frontiers in Cardiovascular Medicine CrossRef
13. MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity
    Ziyu Kuang et al, 2023, Biomolecules CrossRef
14. Noncoding RNAs and Cardiac Fibrosis
    Changyong Wu et al, 2023, Reviews in Cardiovascular Medicine CrossRef
15. PTBP1 as a potential regulator of disease
    Qi Yu et al, 2024, Molecular and Cellular Biochemistry CrossRef